Literature DB >> 28933987

RNA-seq analysis provide new insights into mapk signaling of apolipoproteinciii-induced inflammation in porcine vascular endothelial cells.

Yuan Yue1, Hao Jiang1, Shouqing Yan1, Yao Fu1, Chang Liu1, Xulei Sun1,2, Menglong Chai1,3, Yan Gao1, Bao Yuan1, Chengzhen Chen1, Lisheng Dai1, Jiabao Zhang1, Yu Ding1.   

Abstract

Apolipoprotein CIII (ApoCIII) has been shown to be associated with the inflammatory response, but the mechanism of its inflammatory effects remains unclear. Because vascular endothelial cells (VECs) play a key role in the development of inflammation, the present study was performed to investigate inflammatory mechanisms induced by ApoCIII in VECs. In this study, we screened differentially expressed genes (DEGs) using RNA-sequencing. The results identified 390 up-regulated genes and 257 down-regulated genes. We performed GO functional classification and KEGG pathway analysis for DEGs. Analysis of sequencing data showed that 21 genes were related to the MAPK pathway. Finally, we investigated whether ApoCIII regulates the expression of pro-inflammatory cytokines via MAPK signaling pathway. The results showed that ApoCIII increased the expression levels of IL-6, TNF-α, VCAM-1 and ICAM-1 in VECs. ApoCIII activated the phosphorylation of ERK1/2 and p38 MAPK. An inhibitor of ERK1/2 and p38 MAPK decreased the protein levels of IL-6 and TNF-α. Our findings demonstrate that ApoCIII induces pro-inflammatory cytokine production in VECs via activation of ERK1/2 and p38 MAPK phosphorylation.

Entities:  

Keywords:  ApoCIII; MAPK; RNA-seq; porcine vascular endothelial cells

Mesh:

Substances:

Year:  2017        PMID: 28933987      PMCID: PMC5736343          DOI: 10.1080/15384101.2017.1373222

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  34 in total

Review 1.  MAP kinase pathways.

Authors:  Maosong Qi; Elaine A Elion
Journal:  J Cell Sci       Date:  2005-08-15       Impact factor: 5.285

2.  Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease.

Authors:  Carlos O Mendivil; Eric B Rimm; Jeremy Furtado; Stephanie E Chiuve; Frank M Sacks
Journal:  Circulation       Date:  2011-10-10       Impact factor: 29.690

Review 3.  MAP kinase pathways activated by stress: the p38 MAPK pathway.

Authors:  T Obata; G E Brown; M B Yaffe
Journal:  Crit Care Med       Date:  2000-04       Impact factor: 7.598

4.  Hypertriglyceridemia and delayed clearance of fat load in transgenic rabbits expressing human apolipoprotein CIII.

Authors:  Yinyuan Ding; Yuhui Wang; Hong Zhu; Jianglin Fan; Liqing Yu; George Liu; Enqi Liu
Journal:  Transgenic Res       Date:  2010-12-01       Impact factor: 2.788

5.  Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-kappaB activation.

Authors:  Akio Kawakami; Masanori Aikawa; Noriko Nitta; Masayuki Yoshida; Peter Libby; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-10-12       Impact factor: 8.311

6.  Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice.

Authors:  Y Ito; N Azrolan; A O'Connell; A Walsh; J L Breslow
Journal:  Science       Date:  1990-08-17       Impact factor: 47.728

Review 7.  The role of interleukins in insulin resistance and type 2 diabetes mellitus.

Authors:  Bruno Fève; Jean-Philippe Bastard
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

8.  Apolipoprotein CIII regulates lipoprotein-associated phospholipase A2 expression via the MAPK and NFκB pathways.

Authors:  Xiaolei Han; Tiedong Wang; Jifeng Zhang; Xingxing Liu; Zhuang Li; Gangqi Wang; Qi Song; Daxin Pang; Hongsheng Ouyang; Xiaochun Tang
Journal:  Biol Open       Date:  2015-04-02       Impact factor: 2.422

9.  Alpha-catulin contributes to drug-resistance of melanoma by activating NF-κB and AP-1.

Authors:  Birgit Kreiseder; Yvonne M Holper-Schichl; Barbara Muellauer; Nico Jacobi; Alexander Pretsch; Johannes A Schmid; Rainer de Martin; Harald Hundsberger; Andreas Eger; Christoph Wiesner
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

10.  Role of MAPK in apolipoprotein CIII-induced apoptosis in INS-1E cells.

Authors:  E-ri M Sol; Tea Sundsten; Peter Bergsten
Journal:  Lipids Health Dis       Date:  2009-02-05       Impact factor: 3.876

View more
  3 in total

1.  Is APOC3 the driver of cardiovascular disease in people with type I diabetes mellitus?

Authors:  Henry N Ginsberg; Gissette Reyes-Soffer
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

2.  Host genetics exerts lifelong effects upon hindgut microbiota and its association with bovine growth and immunity.

Authors:  Peixin Fan; Corwin D Nelson; J Danny Driver; Mauricio A Elzo; Francisco Peñagaricano; Kwangcheol C Jeong
Journal:  ISME J       Date:  2021-03-01       Impact factor: 11.217

3.  Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering.

Authors:  Bastian Ramms; Sohan Patel; Xiaoli Sun; Ariane R Pessentheiner; G Michelle Ducasa; Adam E Mullick; Richard G Lee; Rosanne M Crooke; Sotirios Tsimikas; Joseph L Witztum; Philip Lsm Gordts
Journal:  JCI Insight       Date:  2022-07-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.